Ashwath Jayagopal
Chief Scientific & Dev. Ofc. · Opus Genetics, Inc.
- 2026
- Apr 27, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ashwath Jayagopal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $10.15M in IRD purchases and sales in the last 12 months
- Cam Gallagher - $324K in IRD purchases and sales in the last 12 months
- George Magrath - $205K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Benjamin R. Yerxa - $61K in IRD purchases and sales in the last 12 months
- Joseph K. Schachle - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ashwath Jayagopal?
Ashwath Jayagopal is a corporate insider, tracked as Chief Scientific & Dev. Ofc. of Opus Genetics, Inc. (IRD). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ashwath Jayagopal last file a Form 4?
The most recent primary Form 4 on record is dated 27 April 2026, one of 4 filings going back to 2026.
Has Ashwath Jayagopal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($58K) across all tracked filings.
